Sydney, Australia, 25 August 2021 – Clarity Pharmaceuticals was featured in the Australian Financial Review, Australian daily newspaper covering the latest business and economic affairs of Australia and the world.
The article discusses Clarity’s ASX debut, its key investors and the company’s pipeline of products in development.
Read the full article here:
